These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34294091)

  • 1. A questionnaire-based study to comprehensively assess the status quo of rare disease patients and care-givers in China.
    Li X; Liu M; Lin J; Li B; Zhang X; Zhang S; Lu Z; Zhang J; Zhou J; Ou L
    Orphanet J Rare Dis; 2021 Jul; 16(1):327. PubMed ID: 34294091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The urgent need to empower rare disease organizations in China: an interview-based study.
    Li X; Lu Z; Zhang J; Zhang X; Zhang S; Zhou J; Li B; Ou L
    Orphanet J Rare Dis; 2020 Oct; 15(1):282. PubMed ID: 33046132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare disease awareness and perspectives of physicians in China: a questionnaire-based study.
    Li X; Zhang X; Zhang S; Lu Z; Zhang J; Zhou J; Li B; Ou L
    Orphanet J Rare Dis; 2021 Apr; 16(1):171. PubMed ID: 33849615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of 11 national policies for rare diseases in the context of key patient needs.
    Dharssi S; Wong-Rieger D; Harold M; Terry S
    Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is sub-national healthcare social protection sufficient for protecting rare disease patients? the case of China.
    Xu J; Yu M; Zhang Z; Gong S; Li B
    Front Public Health; 2023; 11():1198368. PubMed ID: 37397721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies.
    Dabbous O; Chachoua L; Aballéa S; Sivignon M; Persson U; Petrou S; Richardson J; Simoens S; Toumi M
    Adv Ther; 2023 Feb; 40(2):393-424. PubMed ID: 36451072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Access to Orphan Drugs Covered by Medical Insurance in China: Real-World Evidence From Patient Survey.
    Wang X; Li SC; Yue X; Li Y; Shi N; Zhao FL; Wu J
    Value Health Reg Issues; 2023 Mar; 34():71-77. PubMed ID: 36587572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The availability and affordability of orphan drugs for rare diseases in China.
    Gong S; Wang Y; Pan X; Zhang L; Huang R; Chen X; Hu J; Xu Y; Jin S
    Orphanet J Rare Dis; 2016 Feb; 11():20. PubMed ID: 26920579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological status and quality of life among primary caregivers of individuals with mental illness: a hospital based study.
    Jeyagurunathan A; Sagayadevan V; Abdin E; Zhang Y; Chang S; Shafie S; Rahman RFA; Vaingankar JA; Chong SA; Subramaniam M
    Health Qual Life Outcomes; 2017 May; 15(1):106. PubMed ID: 28526049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rare diseases and their patient organization: the Hungarian Federation of People with Rare and Congenital Diseases].
    Pogány G
    Orv Hetil; 2014 Mar; 155(9):329-33. PubMed ID: 24566696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and related factors of somatization symptoms in outpatients with psychiatric disorders of the department of cardiology in general hospitals].
    Zhang YN; Jin C; Ning L; Gong S; Xiao Y; Yu GL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):907-912. PubMed ID: 31744281
    [No Abstract]   [Full Text] [Related]  

  • 17. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
    Liu BC; He L; He G; He Y
    J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparing for the Future of Rare Diseases.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():641-648. PubMed ID: 29214596
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.